XPA rs2302760: Exploring DNA Repair Variations and UV Sensitivity
The rs2302760 variant is a common single nucleotide polymorphism located in the human XPA gene, which encodes an essential protein in the nucleotide excision repair (NER) pathway. This variant has been investigated for modest influences on cellular DNA repair kinetics following exposure to ultraviolet (UV) photoproducts. Because the available evidence is limited and non-diagnostic, carrying this variant is not considered disease-causing and reflects normal human genetic diversity.
What each genotype means
Typical DNA repair kinetics
You carry two copies of the common C allele at this nucleotide excision repair locus. Research suggests individuals with this genotype exhibit typical baseline XPA-mediated repair kinetics when clearing solar ultraviolet photoproducts. Evidence regarding clinical cancer risk associations for this specific single-nucleotide variant remains limited and inconclusive across diverse populations.
Carried by approximately 30% to 35% of people of European ancestry and roughly 40% to 45% of individuals of East Asian ancestry.
Intermediate repair kinetics profile
You carry one copy of the C allele and one copy of the T allele in the XPA locus. Studies investigating this polymorphic locus indicate intermediate kinetics in cellular nucleotide excision repair assays following ultraviolet radiation exposure. Because published findings on overall health and cancer risk are modest and mixed, this variant does not indicate a monogenic disorder or diagnostic risk on its own.
Found in approximately 45% to 50% of individuals of European ancestry and about 45% to 48% of East Asian populations.
Modulated photoproduct repair kinetics
You carry two copies of the T allele at this XPA gene variant. Cell-based functional studies have noted subtle shifts in the kinetics of nucleotide excision repair and complementation complex activity following UV damage compared to the homozygous reference genotype. Current epidemiological evidence linking these kinetic differences to meaningful differences in cancer susceptibility is limited and conflicting.
Carried by approximately 20% of individuals of European ancestry and roughly 10% to 15% of individuals of East Asian ancestry.
What is rs2302760 and Where is It Found?
The single nucleotide polymorphism rs2302760 is a naturally occurring genetic variant found within the XPA locus on chromosome 9. In dbSNP, rs2302760 designates a base substitution with common alleles typically represented as cytosine (C) and thymine (T). Unlike rare, highly disruptive mutations that completely abolish cellular function, rs2302760 is a common polymorphism found across broad human populations. Because it resides in a non-coding region of the gene, it does not alter the underlying amino acid sequence of the resulting protein directly. Instead, scientific interest has focused on whether the variant subtly affects gene regulation, transcript stability, or local chromatin architecture. Cataloged primarily under observational association frameworks rather than monogenic pathology, rs2302760 serves as a genetic marker to explore how subtle, inherited differences in DNA repair loci contribute to nuanced phenotypic variability in populations.
The Biological Role of the XPA Gene
The XPA gene encodes the xeroderma pigmentosum complementation group A protein, an indispensable scaffold factor within the nucleotide excision repair (NER) machinery. The NER pathway is the human cell's primary defense system against bulky DNA helix distortions, most notably the photoproducts created by solar ultraviolet (UV) radiation, such as cyclobutane pyrimidine dimers and 6-4 photoproducts. When DNA damage occurs, the XPA protein binds to the damaged segment, verifies the structural alteration, and interacts with multiprotein assemblies—including replication protein A and the TFIIH complex—to orchestrate proper excision and repair. Severe loss-of-function mutations in XPA disrupt this machinery entirely, causing the rare autosomal recessive condition xeroderma pigmentosum, characterized by severe photosensitivity and marked skin cancer predisposition. Common variants like rs2302760, however, retain functional protein synthesis and only alter kinetics or cellular efficiency marginally.
Current Scientific Evidence and Clinical Strength
Scientific studies investigating rs2302760 have primarily explored whether specific alleles alter the kinetics of DNA repair after UV-induced cellular stress. While researchers have documented modest differences in repair kinetics and investigated potential associations with environmental cancer risks, overall findings remain classified as limited. Many published association studies on DNA repair polymorphisms evaluate small cohort sizes, leading to heterogeneous results that do not replicate reliably across different ancestral groups. Large meta-analyses and systematic genomic databases demonstrate that rs2302760 does not exert a strong, standalone biological effect. It does not confer diagnosis of xeroderma pigmentosum or any other clinical disorder. Consequently, modern genetic consensus treats rs2302760 as an intriguing trait-level research marker rather than a validated determinant of disease risk.
What You Can and Cannot Conclude From Your Results
Discovering your rs2302760 genotype provides an interesting glimpse into the subtle variations that shape individual cellular biology, but it cannot be used as a personal medical indicator. An individual carrier cannot infer an increased or decreased probability of UV-induced skin damage based on this single variant alone. Universal skin safety practices—such as seeking shade during peak hours, wearing protective clothing, and applying broad-spectrum sunscreen—remain essential for everyone regardless of their DNA repair genotypes. Furthermore, if you encounter variants in DNA repair genes linked to pharmacogenomic interactions (such as platinum-based chemotherapy response), remember that personal treatment decisions should never be altered based on direct-to-consumer testing. Any questions about individual health risks, preventive screenings, or medication responses should be discussed directly with a qualified physician or genetic counselor.
How common is this variant?
The rs2302760 variant is common worldwide, with the minor allele frequency estimated at roughly 0.35 in East Asian populations and approximately 0.45 in populations of European ancestry.
Frequently asked questions
Does having the rs2302760 variant mean I have xeroderma pigmentosum?
No, rs2302760 is a common benign polymorphism found in large proportions of healthy people and does not cause xeroderma pigmentosum. Xeroderma pigmentosum is a rare condition caused by severe, damaging mutations that entirely destroy the function of the XPA protein.
Can this genetic variant tell me if I will get skin cancer?
No, rs2302760 cannot predict whether an individual will develop skin cancer. The evidence connecting this single nucleotide change to cancer risk is limited and statistically modest, while primary risk factors like UV exposure and family history play far larger roles.
Should I change how I use sunscreen based on my genotype?
You should not alter your sun protection habits based on your rs2302760 status. Standard protective behaviors—such as applying broad-spectrum sunscreen, wearing protective hats and eyewear, and limiting midday sun exposure—are recommended for all individuals regardless of their genetics.
Is rs2302760 used in routine clinical genetic testing?
No, clinical testing panels do not evaluate rs2302760 for medical management because its overall impact on human health is not strong enough to guide clinical decisions. It is primarily observed in academic research settings and direct-to-consumer genotyping datasets.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2302760?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29